{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:12Z","timestamp":1792716912465,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamadermatol.2019.4212","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T11:45:05Z","timestamp":1579088705000},"page":"326","source":"Crossref","is-referenced-by-count":46,"title":["Core Outcome Set for Actinic Keratosis Clinical Trials"],"prefix":"10.1001","volume":"156","author":[{"given":"Kelly A.","family":"Reynolds","sequence":"first","affiliation":[{"name":"University of Cincinnati College of Medicine, Cincinnati, Ohio"},{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Schlessinger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Vasic","sequence":"additional","affiliation":[{"name":"Division of Dermatology, College of Medicine Tucson, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Iyengar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West Virginia University, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqoob","family":"Qaseem","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Behshad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Louis University, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"DeHoratius","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Denes","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Drucker","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Dermatology, Department of Medicine, Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard M.","family":"Dzubow","sequence":"additional","affiliation":[{"name":"Private practice, Media, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.","family":"Etzkorn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Harwood","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom"},{"name":"Blizard Institute, Barts and the London School of Medicine and Dentistry, Centre for Cutaneous Research and Cell Biology, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y. S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Lissner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq A.","family":"Marghoob","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubeta N.","family":"Matin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mattox","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat B.","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Regan","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong Alan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zloty","sequence":"additional","affiliation":[{"name":"Department of Dermatology & Skin Science, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Center for Evidence-Based Healthcare, Carl Gustav Carus, TU Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Kirkham","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Sobanko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania, Philadelphia"},{"name":"Division of Dermatologic Surgery, Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd V.","family":"Cartee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Penn State Health, Milton S. Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Maher","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"13","key":"dcs190001r1","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2016.3065","article-title":"Actinic keratosis.","volume":"315","author":"Lebwohl","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"dcs190001r2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/ijd.2007.46.issue-9","article-title":"Actinic keratosis.","volume":"46","author":"Rossi","year":"2007","journal-title":"Int J Dermatol"},{"key":"dcs190001r4","article-title":"Interventions for actinic keratoses.","volume":"12","author":"Gupta","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"dcs190001r5","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"dcs190001r6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13063-015-0738-6","article-title":"Core outcome sets and trial registries.","volume":"16","author":"Clarke","year":"2015","journal-title":"Trials"},{"issue":"3","key":"dcs190001r7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"dcs190001r8","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jid.2018.03.574","article-title":"Acne core outcomes research network: progress in core outcome set development in clinical trials.","volume":"138","author":"Thiboutot","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"dcs190001r9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/bjd.16229","article-title":"The BJD is embracing core outcome set development: why this is good news.","volume":"178","author":"Thomas","year":"2018","journal-title":"Br J Dermatol"},{"issue":"4","key":"dcs190001r10","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1111\/bjd.2018.178.issue-4","article-title":"Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.","volume":"178","author":"Kottner","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"dcs190001r11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bjd.16029","article-title":"Development of an international core outcome set for peripheral vascular malformations: the OVAMA project.","volume":"178","author":"Horbach","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"dcs190001r12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/bjd.14475","article-title":"Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.","volume":"175","author":"Ingram","year":"2016","journal-title":"Br J Dermatol"},{"issue":"10","key":"dcs190001r13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a core domain set to assess psoriasis in clinical trials.","volume":"154","author":"Callis Duffin","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"dcs190001r14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/pcmr.12354","article-title":"Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.","volume":"28","author":"Eleftheriadou","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"dcs190001r15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0.","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"dcs190001r16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider.","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"issue":"1","key":"dcs190001r18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jid.2014.320","article-title":"The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.","volume":"135","author":"Schmitt","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"10","key":"dcs190001r21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002148","article-title":"Core Outcome Set-STAndards for Reporting: the COS-STAR Statement.","volume":"13","author":"Kirkham","year":"2016","journal-title":"PLoS Med"},{"issue":"4","key":"dcs190001r22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/bjd.v181.4","article-title":"Assessing effectiveness in acne clinical trials: steps towards a core outcome measure set.","volume":"181","author":"Thiboutot","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"dcs190001r23","doi-asserted-by":"publisher","first-page":"i","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development.","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technol Assess"},{"issue":"1","key":"dcs190001r25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13063-017-2069-2","article-title":"Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.","volume":"18","author":"Schlessinger","year":"2017","journal-title":"Trials"},{"issue":"1","key":"dcs190001r26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13063-016-1554-3","article-title":"Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.","volume":"17","author":"Iyengar","year":"2016","journal-title":"Trials"},{"issue":"1","key":"dcs190001r27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13063-017-2104-3","article-title":"Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.","volume":"18","author":"Schlessinger","year":"2017","journal-title":"Trials"},{"key":"dcs190001r29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40900-016-0039-6","article-title":"Including patients in core outcome set development: issues to consider based on three workshops with around 100 international delegates.","volume":"2","author":"Young","year":"2016","journal-title":"Res Involv Engagem"},{"issue":"11","key":"dcs190001r30","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3899\/jrheum.141156","article-title":"Enhanced patient involvement and the need to revise the core set\u2014report from the Psoriatic Arthritis Working Group at OMERACT 2014.","volume":"42","author":"Tillett","year":"2015","journal-title":"J Rheumatol"},{"key":"dcs190001r31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40900-018-0091-5","article-title":"Defining and evaluating novel procedures for involving patients in Core Outcome Set research: creating a meaningful long list of candidate outcome domains.","volume":"4","author":"Smith","year":"2018","journal-title":"Res Involv Engagem"},{"issue":"3","key":"dcs190001r32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172937","article-title":"A review of patient and carer participation and the use of qualitative research in the development of core outcome sets.","volume":"12","author":"Jones","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"dcs190001r33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/jdv.2018.32.issue-7","article-title":"Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.","volume":"32","author":"Philipp-Dormston","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dcs190001r34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jdv.2019.33.issue-1","article-title":"Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.","volume":"33","author":"Neri","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"dcs190001r35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamadermatol.2016.4733","article-title":"Variation in the cost of managing actinic keratosis.","volume":"153","author":"Kirby","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dcs190001r36","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/jid.2011.459","article-title":"Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.","volume":"132","author":"Surjana","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"dcs190001r37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial.","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"dcs190001r24","author":"Fish"},{"key":"dcs190001r3","unstructured":"ClinicalTrials.gov. National Institute of Health US National Library of Medicine.https:\/\/clinicaltrials.gov\/. Accessed March 12, 2019."},{"key":"dcs190001r17","unstructured":"CSG-COUSIN Methods Group. Guidance on how to develop a core outcome set for skin disease by the CSG-COUSIN methods group. Version 2.1. https:\/\/www.uniklinikum-dresden.de\/de\/das-klinikum\/universitaetscentren\/zegv\/cousin\/cousin_guidance_version_2-1.pdf. Updated December 14, 2017. Accessed February 27, 2019."},{"key":"dcs190001r19","unstructured":"COMET Initiative. Core outcome set for actinic keratosis. http:\/\/www.comet-initiative.org\/studies\/searchresults?guid=be343b10-f9b9-46fb-80ed-9ffe9bf7bff9. Accessed February 27, 2019."},{"key":"dcs190001r20","unstructured":"Cochrane Skin Group Core Outcome Set Initiative. Project groups. https:\/\/www.uniklinikum-dresden.de\/de\/das-klinikum\/universitaetscentren\/zegv\/cousin\/meet-the-teams\/project-groups. Accessed February 27, 2019."},{"key":"dcs190001r28","unstructured":"BoersM, KirwanJR, TugwellP, . The OMERACT Handbook. https:\/\/omeract.org. Updated January 19, 2018. Accessed February 27, 2019."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2758800\/jamadermatology_reynolds_2020_cs_190001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:08:15Z","timestamp":1583924895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2758800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.4212","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}